Literature DB >> 29547829

Atypical pyridoxine dependent epilepsy resulting from a new homozygous missense mutation, in ALDH7A1.

Zahraa Haidar1, Nadine Jalkh2, Sandra Corbani3, Ali Fawaz4, Eliane Chouery5, André Mégarbané6.   

Abstract

Pyridoxine dependent epilepsy (PDE) is a rare autosomal recessive neurometabolic disorder. In the classical form, seizures are observed within the first month of life, while in the atypical form seizures appear later in life, sometimes as late as at the age of 3 years of life. Both types are unresponsive to conventional anticonvulsant therapy, but can be controlled with pyridoxine monotherapy. Mutations in the ALDH7A1 gene, encoding α-aminoadipic semialdehyde dehydrogenase have been reported to cause this disease in most patients. Here, we report on a boy with developmental delay, dysmorphic facial features, and uncontrolled episodes of seizures that appeared at the age of 18 months. By whole exome sequencing (WES) a homozygous missense mutation in ALDH7A1 (NM_001182: c.239T > G, p.V80G) was found. We discuss the importance of WES in such atypical cases.
Copyright © 2018 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ALDH7A1; Pyridoxine-dependent epilepsy; Whole exome sequencing

Mesh:

Substances:

Year:  2018        PMID: 29547829     DOI: 10.1016/j.seizure.2018.03.010

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  2 in total

1.  A case for newborn screening for pyridoxine-dependent epilepsy.

Authors:  Curtis R Coughlin; Laura A Tseng; Clara D M van Karnebeek
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-03-24

2.  An Atypical Presentation of Pyridoxine-Dependent Epilepsy Diagnosed with Whole Exome Sequencing and Treated with Lysine Restriction and Supplementation with Arginine and Pyridoxine.

Authors:  Jiyoung Kim; Angela Pipitone Dempsey; Sun Young Kim; Meral Gunay-Aygun; Hilary J Vernon
Journal:  Case Rep Genet       Date:  2022-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.